Found: 9
Select item for more details and to access through your institution.
Evaluation of Proton Pump Inhibitor Esomeprazole on Crizotinib Pharmacokinetics in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 1, p. 34, doi. 10.1002/cpdd.1032
- By:
- Publication type:
- Article
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma.
- Published in:
- European Journal of Endocrinology, 2022, v. 186, n. 6, p. 631, doi. 10.1530/eje-21-1259
- By:
- Publication type:
- Article
Phase I Trial of the HSP90 Inhibitor PF-04929113 (SNX5422) in Adult Patients With Recurrent, Refractory Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 4, p. 385, doi. 10.1016/j.clml.2013.03.010
- By:
- Publication type:
- Article
Effects of Renal Function on Crizotinib Pharmacokinetics: Dose Recommendations for Patients with ALK-Positive Non-Small Cell Lung Cancer.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 4, p. 363, doi. 10.1007/s40261-016-0490-z
- By:
- Publication type:
- Article
The effects of ketoconazole and rifampin on the single-dose pharmacokinetics of crizotinib in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 12, p. 1441, doi. 10.1007/s00228-015-1945-5
- By:
- Publication type:
- Article
Evaluation of crizotinib absolute bioavailability, the bioequivalence of three oral formulations, and the effect of food on crizotinib pharmacokinetics in healthy subjects.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 1, p. 104, doi. 10.1002/jcph.356
- By:
- Publication type:
- Article
Prevalence and clinico-genomic characteristics of patients with TRK fusion cancer in China.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00427-3
- By:
- Publication type:
- Article
Prevalence and clinico-genomic characteristics of patients with TRK fusion cancer in China.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00427-3
- By:
- Publication type:
- Article
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. e779, doi. 10.1093/oncolo/oyac080
- By:
- Publication type:
- Article